Project description
Optimising mobile laboratories for disease-monitoring missions
Rapid response mobile laboratories (RRMLs) are key to quickly responding to and monitoring diseases. However, their successful deployment depends on the operational capacities of users. The EU-funded ONELAB project aims to develop a modular RRML for fast, flexible and scalable use in as many settings and scenarios as possible. In addition, it will create advanced measurement systems, and devise and demonstrate a workflow for semi-autonomous disease-specific biomarker discovery. Training and networking events will improve key actors’ capabilities and capacities. A citizen’s guide to mass community testing and educational outreach resources will boost public engagement and acceptance.
Objective
Expert opinion from across the world recommends, & calls for, modular laboratory systems to be made available for disease monitoring missions. The WHO calls these, “Rapid Response Mobile Laboratories” (RRML). ONELAB will develop modular RRML for rapid, flexible, scalable, multi-scenario deployments into the widest range of possible settings. These next-generation facilities will support next-generation measurement-technologies/methodologies and, through satellite communications, form wide-area GIS enabled laboratory information systems. Thus, simultaneously providing point-of-need disease detection, along with high-level situational awareness.
ONELAB will also develop advanced measurement systems for a staged disease detection response. Exploiting a panel of acute viral infection biomarkers enables early detection of disease during its asymptomatic incubation. Using this at the outbreak of disease, when much is still undefined, supports effective immediate & targeted public health interventions. Additionally, using proven methodologies developed in response to COVID 19, ONELAB will develop & demonstrate a workflow for semi-autonomous disease specific biomarker discovery. This application & delivery of agile science enhances the capability & capacity of current disease testing-strategies substantially
RRMLs are only as good as the skilled teams who operate them. So, ONELAB builds world-wide networks & partnerships of experienced experts to: define contextually-aligned best practice; develop a consensus-driven concepts of operation; and, disseminate this though a pandemic testing playbook. We will develop capability & capacity with training & networking-events that continue beyond the project. Finally, community mass-testing requires engagement & acceptance from all citizens, which is why we will engage with the public, & produce a citizen’s guide to mass community testing, supported by educational outreach resources.
Fields of science
Keywords
Programme(s)
Funding Scheme
HORIZON-IA - HORIZON Innovation ActionsCoordinator
1081 HV Amsterdam
Netherlands
See on map
Participants (18)
6051 Larnaca
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
15561 ATHINA
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
350-0495 Saitama
See on map
176 71 Athina
See on map
6020 Innsbruck
See on map
3540 Herk De Stad
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1678 Nicosia
See on map
7622 Pecs
See on map
4040 Linz
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
9000 Gent
See on map
115 24 NEA FILOTHEI ATHINA
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
34170 Gorizia
See on map
1210 Wien
See on map
81373 Munchen
See on map
3500 Hasselt
See on map
1051 Budapest
See on map
26441 PATRAS
See on map
44227 Dortmund
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partners (3)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
LE2 3TH LEICESTER
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
CF45 4SN Abercynon
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
CB6 1RA Ely
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.